<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title49.html">
                                    Title 49
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/49CFR40.html">Part 40
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 40.91  What validity tests must laboratories conduct on primary
                            </h3>
                            <p class="depth0">As a laboratory, when you conduct validity testing under Sec.  40.89, you must conduct it in accordance with the requirements of this  section.</p><p class="depth1"><em>(a)</em> You must determine the creatinine concentration on each primary  specimen. You must also determine its specific gravity if you find the  creatinine concentration to be less than 20 mg/dL.</p><p class="depth1"><em>(b)</em> You must determine the pH of each primary specimen.</p><p class="depth1"><em>(c)</em> You must perform one or more validity tests for oxidizing  adulterants on each primary specimen.</p><p class="depth1"><em>(d)</em> You must perform additional validity tests on the primary  specimen when the following conditions are observed:</p><p class="depth2"><em>(1)</em> Abnormal physical characteristics;</p><p class="depth2"><em>(2)</em> Reactions or responses characteristic of an adulterant obtained  during initial or confirmatory drug tests (e.g., non-recovery of  internal standards, unusual response); or</p><p class="depth2"><em>(3)</em> Possible unidentified interfering substance or adulterant.</p><p class="depth1"><em>(e)</em> If you determine that the specimen is invalid and HHS guidelines  direct you to contact the MRO, you must contact the MRO and together  decide if testing the primary specimen by another HHS certified  laboratory would be useful in being able to report a positive or  adulterated test result.  [65 FR 79526, Dec. 19, 2000, as amended at 69 FR 64867, Nov. 9, 2004]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
